Trial
NCT04120987
Ocular Inflammation in Cataract Patients and Response to Treatment With Xiidra
Phase IVWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Bucci Laser Vision Institute
Collaborators
—
Condition
Dry Eye
Intervention
Lifitegrast 5% Ophthalmic Solution
Why stopped
Administrative
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-07-27